Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
REVOLUTION Medicines
Sort By
Newest First
1 / 1
1 / 1
Partner
Revolution Medicines and Amgen Partner on Phase 1b Study to Evaluate Combination of RMC-4630 and AMG 510
REVOLUTION Medicines, Inc.
PR-M11-19-NI-004
Nov 05, 2019
Financing
REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers
REVOLUTION Medicines, Inc.
PR-M07-19-NI-034
Jul 15, 2019
